JP2024500136A5 - - Google Patents

Info

Publication number
JP2024500136A5
JP2024500136A5 JP2023537316A JP2023537316A JP2024500136A5 JP 2024500136 A5 JP2024500136 A5 JP 2024500136A5 JP 2023537316 A JP2023537316 A JP 2023537316A JP 2023537316 A JP2023537316 A JP 2023537316A JP 2024500136 A5 JP2024500136 A5 JP 2024500136A5
Authority
JP
Japan
Prior art keywords
oxopyrrolidine
butan
dioxo
cyclopropylamino
dimethylpentanamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023537316A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500136A (ja
Filing date
Publication date
Priority claimed from GBGB2020190.1A external-priority patent/GB202020190D0/en
Priority claimed from GBGB2107385.3A external-priority patent/GB202107385D0/en
Application filed filed Critical
Priority claimed from PCT/GB2021/053374 external-priority patent/WO2022129953A1/en
Publication of JP2024500136A publication Critical patent/JP2024500136A/ja
Publication of JP2024500136A5 publication Critical patent/JP2024500136A5/ja
Pending legal-status Critical Current

Links

JP2023537316A 2020-12-18 2021-12-20 Sars-cov-2 mpro阻害薬化合物 Pending JP2024500136A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB2020190.1A GB202020190D0 (en) 2020-12-18 2020-12-18 Sars-Cov-2 MPRO inhibitor compounds
GB2020190.1 2020-12-18
GBGB2107385.3A GB202107385D0 (en) 2021-05-24 2021-05-24 Sars-cov-2 mpro inhibitor compounds
GB2107385.3 2021-05-24
PCT/GB2021/053374 WO2022129953A1 (en) 2020-12-18 2021-12-20 Sars-cov-2 mpro inhibitor compounds

Publications (2)

Publication Number Publication Date
JP2024500136A JP2024500136A (ja) 2024-01-04
JP2024500136A5 true JP2024500136A5 (cg-RX-API-DMAC7.html) 2024-12-26

Family

ID=79282959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023537316A Pending JP2024500136A (ja) 2020-12-18 2021-12-20 Sars-cov-2 mpro阻害薬化合物

Country Status (8)

Country Link
US (1) US20240083845A1 (cg-RX-API-DMAC7.html)
EP (1) EP4263502B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024500136A (cg-RX-API-DMAC7.html)
KR (1) KR20230121780A (cg-RX-API-DMAC7.html)
AU (1) AU2021402179A1 (cg-RX-API-DMAC7.html)
CA (1) CA3204314A1 (cg-RX-API-DMAC7.html)
IL (1) IL303757A (cg-RX-API-DMAC7.html)
WO (1) WO2022129953A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023249007A1 (cg-RX-API-DMAC7.html) * 2022-06-23 2023-12-28
CN115073347B (zh) * 2022-07-14 2024-07-30 浙江江北药业有限公司 一种内酰胺环类医药中间体的制备方法
WO2024102455A1 (en) * 2022-11-09 2024-05-16 Emory University Non-covalent inhibitors of coronavirus main protease
CN116535460A (zh) * 2023-04-28 2023-08-04 中国人民解放军军事科学院军事医学研究院 一类含硫拟肽类化合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763576A (en) * 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
HUP0004400A3 (en) * 1997-11-05 2002-10-28 Novartis Ag Dipeptide nitriles, process for their preparation, pharmaceutical compositions comprising thereof and their use
WO2004093860A1 (en) * 2003-04-21 2004-11-04 Pfizer Inc. Inhibitors of sars related coronavirus proteinase
WO2005113580A1 (en) * 2004-05-21 2005-12-01 Pfizer Inc. Anticoronviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
CN100363346C (zh) * 2004-10-22 2008-01-23 清华大学 冠状病毒主蛋白酶的小分子抑制剂、制备方法及其应用
WO2006061714A2 (en) * 2004-12-09 2006-06-15 Pfizer Inc. Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
CA2850003C (en) * 2011-09-27 2020-01-07 Kansas State University Research Foundation Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
CN103130710B (zh) * 2011-11-29 2015-12-16 南开大学 抗肠病毒71(ev71)己内酰胺醛类化合物及其制备方法和用途
CN103145608B (zh) * 2011-12-07 2015-09-02 南开大学 抗肠病毒71(ev71)己内酰胺类化合物及其制备方法和用途
UY37381A (es) * 2016-08-30 2018-03-23 Glaxosmithkline Ip No 2 Ltd Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos
CN110818691A (zh) * 2018-08-09 2020-02-21 中国科学院上海药物研究所 酮酰胺类化合物及其制备方法、药物组合物和用途

Similar Documents

Publication Publication Date Title
JP2022043059A5 (cg-RX-API-DMAC7.html)
RU2356893C2 (ru) Ингибиторы фосфодиэстеразы 4
JP2023123854A5 (cg-RX-API-DMAC7.html)
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
RU2411238C2 (ru) Цис-2,4,5-триарилимидазолины и их применение в качестве противораковых лекарственных средств
RU2337098C2 (ru) Новые производные бензимидазола и фармацевтическая композиция на их основе для использования в лечении расстройств, опосредованных vr1
RU2010120682A (ru) Ингибиторы гистондезацетилазы
JP2021529812A5 (cg-RX-API-DMAC7.html)
JP2022534979A5 (cg-RX-API-DMAC7.html)
RU2494089C2 (ru) Соединения, представляющие собой стиролильные производные, для лечения офтальмических заболеваний и расстройств
JP2024530952A5 (cg-RX-API-DMAC7.html)
JP2021515004A5 (cg-RX-API-DMAC7.html)
RU2389719C2 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2020506171A5 (cg-RX-API-DMAC7.html)
JP2012515166A5 (cg-RX-API-DMAC7.html)
JP2023547241A5 (cg-RX-API-DMAC7.html)
JP2005536475A5 (cg-RX-API-DMAC7.html)
JP2008505874A5 (cg-RX-API-DMAC7.html)
RU2011101951A (ru) Способ получения стимулятора апоптоза авт-263
RU2001126559A (ru) Активаторы глюкокиназы
RU2005124360A (ru) Новые обратные агонисты рецептора св 1
RU2007119427A (ru) Соединения, являющиеся ингибиторами гликогенфосфорилазы, и фармацевтические композиции на их основе
RU2015143675A (ru) Ship1 модуляторы и относящиеся к ним способы
JP2017538697A5 (cg-RX-API-DMAC7.html)